The Journal of Bone and Joint Surgery (American). 2007;89:792-797.
doi:10.2106/JBJS.F.00414
© 2007 The Journal of Bone and Joint Surgery, Inc.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the activities for this article:
Adult Knee Reconstruction Test 15: Summer 2007 (publication date August 15,...
Oncology Test 5: Winter 2008 (publication date February 15, 2008; expiratio...
Right arrow Letters to the Editor: Submit a response
Right arrow Letters to the Editor: View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Darouiche, R. O.
Right arrow Articles by Landon, G. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Darouiche, R. O.
Right arrow Articles by Landon, G. C.
Related Collections
Right arrow Basic Science
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Facebook   Add to Technorati   Add to Twitter  
What's this?

In Vivo Efficacy of Antimicrobial-Coated Devices

Rabih O. Darouiche, MD1, Mohammad D. Mansouri, BS2, Devin Zakarevicz, PA3, Atef AlSharif, MD2 and Glenn C. Landon, MD3

1 Center for Prostheses Infection, Baylor College of Medicine, 1333 Moursund Avenue, Suite A221, Houston, TX 77030. E-mail address: rdarouiche{at}aol.com
2 Spinal Cord Injury Laboratory, Michael E. DeBakey Veterans Affairs Medical Center, Room 178, 2002 Holcombe Boulevard., Houston, TX 77030. E-mail address for M.D. Mansouri: mansouri{at}bcm.tmc.edu. E-mail address for A. AlSharif: alsharif{at}bcm.tmc.edu
3 Section of Orthopedic Surgery, Kelsey-Seybold Clinic, 2727 West Holcombe Boulevard, Houston, TX 77025. E-mail address for D. Zakarevicz: dmzakarevicz{at}kelsey-seybold.com. E-mail address for G.C. Landon: gclandon{at}kelsey-seybold.com

Investigation performed at the Center for Prostheses Infection, Baylor College of Medicine; the Section of Orthopedic Surgery, Kelsey-Seybold Clinic; and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas

Disclosure: In support of their research for or preparation of this work, one or more of the authors received, in any one year, outside funding or grants in excess of $10,000 from Biomet Orthopedics, Inc, and funding or grants of less than $10,000 from the Department of Veterans Affairs. In addition, one or more of the authors or a member of his or her immediate family received, in any one year, payments or other benefits of less than $10,000 or a commitment or agreement to provide such benefits from a commercial entity (Biomet Orthopedics, Inc.). Also, a commercial entity (Biomet Orthopedics, Inc.) paid or directed in any one year, or agreed to pay or direct, benefits in excess of $10,000 to a research fund, foundation, division, center, clinical practice, or other charitable or nonprofit organization with which the authors, or a member of their immediate families, are affiliated or associated.


Background: Since device colonization is a prelude to infection, an antimicrobial-coated device that reduces bacterial colonization can potentially protect against infection. The objective of this animal study was to assess the efficacy of a coating with minocycline and rifampin to prevent colonization of a grit-blasted titanium implant and subsequent osteomyelitis.

Methods: Twenty-five rabbits underwent implantation of a titanium-alloy pin, either coated with minocycline and rifampin (thirteen rabbits) or uncoated (twelve rabbits), into the right femoral medullary canal. The implanted devices were inoculated with 500 CFU (colony-forming units) of Staphylococcus aureus prior to wound closure. The rabbits were killed one week later, and the removed device, femoral bone, a specimen obtained by swabbing the track surrounding the device, and blood were cultured. The rates of device colonization, osteomyelitis, and device-related osteomyelitis were compared between the two groups of rabbits.

Results: The antimicrobial-coated devices had a significantly lower rate of colonization than the uncoated devices (five of thirteen compared with twelve of twelve, p = 0.0016) and were associated with significantly lower rates of osteomyelitis (six of thirteen compared with twelve of twelve, p = 0.005) and device-related osteomyelitis (five of thirteen compared with twelve of twelve, p = 0.0016). Bacteremia did not develop in any rabbit.

Conclusions: Orthopaedic devices coated with minocycline and rifampin significantly protected against device colonization and infection due to Staphylococcus aureus in this in vivo rabbit model.

Clinical Relevance: It is possible that orthopaedic devices coated with this unique combination of antimicrobial agents may protect against the development of clinical infection in humans.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Facebook Facebook   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


Letters to the Editor:

Read all Letters to the Editor

Rifampin-minocycline Coated Orthopaedic Implants - Is There a Need for Caution?
Devdatta S Neogi, MS(Ortho), DNB(Orth Surg), et al.
JBJS Online, 17 Mar 2008 [Full text]
Dr. Darouiche responds to Dr. Neogi et al.
Rabih O Darouiche, M.D.
JBJS Online, 17 Mar 2008 [Full text]